Uganda's efforts to combat the HIV/AIDS epidemic have made significant strides, yet crucial gaps remain, particularly in preventing mother-to-child transmission of the virus.

The U.S Food and Drug Administration ( FDA) has confirmed the availability of lenacapavir, a two-yearly injectable HIV/ADS treatment as early as the summer 2025, a decision made by FDA after the ...

The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...

Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...

The AIDS Society of India (ASI) has called on the government to swiftly integrate HIV self-testing and pre-exposure ...

New report shows an increase in HIV cases in Alberta. Experts tell Hiba Kamal-Choufi there should be a holistic approach to ...

Some aspects of these treatment plans may be feasible ... and cumulative live-birth rate (CLBR), while rates of HIV seroconversion and vertical transmission are measures of the safety of the ...

Since the vertical transmission rate is associated with ... and new antiretroviral agents have since been introduced for the treatment of HIV-1 infection. HAART has increased the survival and ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Historically, as mentioned, PrEP has been used to treat cisgender gay men, especially in light of the HIV crisis of the 1980s ...

Dr Ayoade Alakija, outlines the negative effects of vaccine nationalism and emphasizes the importance of countries ...